TUESDAY, Oct. 4, 2022 (HealthDay News) — While certain minority groups are more likely to be diagnosed with dementia than their white counterparts, they may also be less likely to be eligible for new disease-slowing treatments, a new study finds. Cognitive, or mental, impairment in Black, Hispanic and Asian patientsContinue Reading

MONDAY, Oct.3 2022 (HealthDay News) — Larry Griner resigned from his job in California and moved back to his childhood home in Baltimore nearly five years ago so he could care for his mother, Norma. She had been diagnosed with Alzheimer’s disease almost 12 years earlier, which took away herContinue Reading

WEDNESDAY, Sept. 28, 2022 (HealthDay) — Japanese drugmaker Eisai on Wednesday said its experimental drug lecanemab helped slow thinking declines among people in the early stages of Alzheimer’s disease. The findings from a phase 3 clinical trial have yet to be peer-reviewed in any medical journal. But according to aContinue Reading

FRIDAY, Sept. 16, 2022 (HealthDay News) — COVID-19 infection may significantly boost an older person’s risk of developing Alzheimer’s disease, a new, large-scale study suggests. People 65 and older who contracted COVID were nearly 70% more likely overall to be diagnosed with Alzheimer’s within a year of their infection, researchersContinue Reading